Buy Intellia Therapeutics Stock | NTLA Stock Price & Latest News | Public
NTLA

Intellia Therapeutics

$0.00 (0.00%)Today

    About NTLA

    Intellia Therapeutics, Inc. engages in the development of gene editing-based therapies. It provides scientific expertise, clinical development, and intellectual property position to unlock broad therapeutic applications of CRISPR or Cas9 genome editing and develop a pot...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.21
    -0.42
    -0.63
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.61

    Actual EPS
    Q4 2020

    Stats

    Market Cap$2,42B
    Volume56,57k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$41.81
    1 Year Low$9.18
    Open$41.74
    High$43.70
    Low$40.01

    Buy any stock with any amount of money.

    Download the App
    Download the app